Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
Hypertension and Diabetes: Emerging Therapies and Complications
This episode explores the latest research on hypertension management in diabetes, including renal denervation outcomes, β-blocker use, diabetic complications, and emerging therapies like semaglutide, with insights from leading researchers in the field.
Bibliography
1. Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reports.
Authors: Mahfoud F, Kandzari DE, Schlaich MP, et al.
Journal: European journal of preventive cardiology, 2026 May 15
PMID: 40676971
DOI: 10.1093/eurjpc/zwaf368
2. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.
Authors: Thipsawat S
Journal: Diabetes & vascular disease research, 2021 Nov-Dec
PMID: 34791910
DOI: 10.1177/14791641211058856
3. SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.
Authors: Bel Lassen P, Jacobi D, Brindisi MC, et al.
Journal: Diabetes, obesity & metabolism, 2026 Jun
PMID: 41884974
DOI: 10.1111/dom.70697
4. Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies.
Authors: Chrzanowski J, Walicka M, Burzyński J, et al.
Journal: PLoS medicine, 2026 May
PMID: 42166479
DOI: 10.1371/journal.pmed.1005064
5. The Role of β-Blockers in the Evolving Treatment Landscape of Resistant Hypertension.
Authors: Masi S, Pathak A, Bruno RM, et al.
Journal: Drugs, 2026 Jun
PMID: 42002646
DOI: 10.1007/s40265-026-02319-9
6. CHRONIC COMPLICATIONS OF DIABETES AND QUALITY OF LIFE.
Authors: Kolarić V, Svirčević V, Bijuk R, et al.
Journal: Acta clinica Croatica, 2022 Nov
PMID: 37492372
DOI: 10.20471/acc.2022.61.03.18
7. The MAIA trial: Protocol of a prospective randomized controlled trial to evaluate the impact of an omega-3 polyunsaturated fatty acids-enriched diet on the loss of independence in nursing home residents.
Authors: Billy C, Bajeux E, Mairesse G, et al.
Journal: Clinical nutrition ESPEN, 2026 Jun
PMID: 42019884
DOI: 10.1016/j.clnesp.2026.103302
8. Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta-Analysis of a Potential Therapeutic Target.
Authors: Luk JTF, Lin AH, Cheung EKC, et al.
Journal: The Prostate, 2026 Jun
PMID: 42018554
DOI: 10.1002/pros.70187
9. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease.
Authors: Jia G, Sowers JR
Journal: Hypertension (Dallas, Tex. : 1979), 2021 Nov
PMID: 34601960
DOI: 10.1161/HYPERTENSIONAHA.121.17981
10. Clinical Diabetic Peripheral Neuropathy: Can It Be Reversed? Arguments for and Against From a NEUROdiab Debate.
Authors: Sloan G, Azmi S, Eid S, et al.
Journal: Journal of the peripheral nervous system : JPNS, 2026 Jun
PMID: 42144696
DOI: 10.1111/jns.70124
Authors: Mahfoud F, Kandzari DE, Schlaich MP, et al.
Journal: European journal of preventive cardiology, 2026 May 15
PMID: 40676971
DOI: 10.1093/eurjpc/zwaf368
2. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.
Authors: Thipsawat S
Journal: Diabetes & vascular disease research, 2021 Nov-Dec
PMID: 34791910
DOI: 10.1177/14791641211058856
3. SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.
Authors: Bel Lassen P, Jacobi D, Brindisi MC, et al.
Journal: Diabetes, obesity & metabolism, 2026 Jun
PMID: 41884974
DOI: 10.1111/dom.70697
4. Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies.
Authors: Chrzanowski J, Walicka M, Burzyński J, et al.
Journal: PLoS medicine, 2026 May
PMID: 42166479
DOI: 10.1371/journal.pmed.1005064
5. The Role of β-Blockers in the Evolving Treatment Landscape of Resistant Hypertension.
Authors: Masi S, Pathak A, Bruno RM, et al.
Journal: Drugs, 2026 Jun
PMID: 42002646
DOI: 10.1007/s40265-026-02319-9
6. CHRONIC COMPLICATIONS OF DIABETES AND QUALITY OF LIFE.
Authors: Kolarić V, Svirčević V, Bijuk R, et al.
Journal: Acta clinica Croatica, 2022 Nov
PMID: 37492372
DOI: 10.20471/acc.2022.61.03.18
7. The MAIA trial: Protocol of a prospective randomized controlled trial to evaluate the impact of an omega-3 polyunsaturated fatty acids-enriched diet on the loss of independence in nursing home residents.
Authors: Billy C, Bajeux E, Mairesse G, et al.
Journal: Clinical nutrition ESPEN, 2026 Jun
PMID: 42019884
DOI: 10.1016/j.clnesp.2026.103302
8. Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta-Analysis of a Potential Therapeutic Target.
Authors: Luk JTF, Lin AH, Cheung EKC, et al.
Journal: The Prostate, 2026 Jun
PMID: 42018554
DOI: 10.1002/pros.70187
9. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease.
Authors: Jia G, Sowers JR
Journal: Hypertension (Dallas, Tex. : 1979), 2021 Nov
PMID: 34601960
DOI: 10.1161/HYPERTENSIONAHA.121.17981
10. Clinical Diabetic Peripheral Neuropathy: Can It Be Reversed? Arguments for and Against From a NEUROdiab Debate.
Authors: Sloan G, Azmi S, Eid S, et al.
Journal: Journal of the peripheral nervous system : JPNS, 2026 Jun
PMID: 42144696
DOI: 10.1111/jns.70124
